Comparison of nasal calcitonin and oral gabapentin effect on treatment Symptomatic Spinal Canal Stenosis

Comparison of nasal calcitonin and oral gabapentin effect on ability of daily skill patients with spinal canal stenosis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014091519185N1

Enrollment

Registered

2014-11-24

Start date

2013-02-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal stenosis. Spinal stenosis

Interventions

Intervention 1: gabapentine,300mg oral,bid,4 weeks. Intervention 2: calcitonin,200 unite,nasal spray,daily,4 weeks.

Treatment - Drugs

gabapentine,300mg oral,bid,4 weeks

calcitonin,200 unite,nasal spray,daily,4 weeks

Eligibility

Sex/Gender

Female

Age

45 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age above 45 years old; female; low back or leg pain; paraestesia; neurological cladication; areflexia; radiologic evidence(diameter upper13 mm in MRI). Exclusion criteria: patient disagrement; vascular claudication; symptomatic hip/knee pathology; previous lumbar spinal surgery; renal failure; pregnancy; malignancy; present of other neurological disease including diabetic neuropathy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Ability of daily skill. Timepoint: Pre intervention,4 weeks after intervention,2 weeks after cut of intervention. Method of measurement: Oswestry disability index.	—

Secondary

Measure	Time frame
Parestesia. Timepoint: Pre intervention,4 weeks after intervention,2 weeks after cut intervention. Method of measurement: Physical examination.;Neurological claudication. Timepoint: Pre intervention,4 weeks after intervention,2 weeks after cut intervention. Method of measurement: Physical examination.;Low back pain. Timepoint: Pre intervention,4 weeks after intervention,2 weeks after cut intervention. Method of measurement: Pwestery disability index.	—

Measure

Time frame

Parestesia. Timepoint: Pre intervention,4 weeks after intervention,2 weeks after cut intervention. Method of measurement: Physical examination.;Neurological claudication. Timepoint: Pre intervention,4 weeks after intervention,2 weeks after cut intervention. Method of measurement: Physical examination.;Low back pain. Timepoint: Pre intervention,4 weeks after intervention,2 weeks after cut intervention. Method of measurement: Pwestery disability index.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLeila Asadian

Diabetes Research Center, Mazandaran University Of Medical Science

DMRC@MAZUMS.AC.IR+98 113378789

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026